X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-04-15 | SST | System1, Inc. | Kidambi Tridivesh | CFO | P - Purchase | $3.00 | +26,910 | 146,515 | +22% | +$80,730 | ||||||
| M | 2026-04-15 | BZUN | Baozun Inc. | Qiu Wenbin | CEO | P - Purchase | $2.79 | +28,500 | 1,417,872 | +2% | +$79,510 | |||||
2026-04-16 | YORW | York Water Co | Hand Joseph Thomas | CEO, Pres | P - Purchase | $28.50 | +1,052 | 41,433 | +3% | +$29,982 | ||||||
2026-04-17 | GAM | General American Investors Co Inc | Majmudar Anang K. | Senior Vice-Pres | P - Purchase | $24.81 | +1,000 | 50,342 | +2% | +$24,810 | ||||||
2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Skibsted Russell | CFO | P - Purchase | $2.97 | +1,984 | 4,308 | +85% | +$5,892 | ||||||
2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO | P - Purchase | $2.97 | +1,843 | 9,780 | +23% | +$5,474 | ||||||
2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Officer | P - Purchase | $2.97 | +1,799 | 5,777 | +45% | +$5,343 | ||||||
2026-04-16 | YORW | York Water Co | Poff Matthew E | CFO | P - Purchase | $28.50 | +175 | 8,451 | +2% | +$4,988 | ||||||
2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Guy Wendy | Chief Administrative Officer | P - Purchase | $2.97 | +1,583 | 5,026 | +46% | +$4,702 | ||||||
2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Young David | Pres Research, Development | P - Purchase | $2.97 | +1,545 | 14,523 | +12% | +$4,589 | ||||||
2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $2.97 | +1,369 | 6,465 | +27% | +$4,066 | ||||||
2026-04-16 | YORW | York Water Co | Scarpato Matthew J | COO | P - Purchase | $29.13 | +103 | 1,074 | +11% | +$3,000 | ||||||
2026-04-15 | FFAI | Faraday Future Intelligent Electric Inc. | Aydt Matthias | Co-Global CEO | P - Purchase | $100.00 | +1 | 1 | New | +$100 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |